Infinium Pharmachem was incorporated on November 2003. The company is in the business of manufacturing and supplying Iodine, iodine derivatives and active pharmaceutical ingredients.
| Bidding Dates |
|---|
| 31 Mar 2023 - 05 Apr 2023 |
| Subscription |
|---|
| 1.88x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹1,35,000 | 1 | 1 | 1000 | 1.9 M | ₹135 | 73.05 % | ₹253.1 M | RHP DOC |
Infinium Pharmachem IPO SUBSCRIPTION STATUS
05 Apr '23Infinium Pharmachem IPO overall subscription rate was 1.88 times the total available shares
Infinium Pharmachem IPO retail subscription rate was 1.86 times in the retail segment
Infinium Pharmachem IPO non-institutional investor subscription rate was 1.8 times in the non-institutional investor category
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 50% | 50% | - |
05 Apr 2023 (Day 3) | 1.86x | 1.8x | - |
03 Apr 2023 (Day 2) | 0.55x | 0.31x | - |
31 Mar 2023 (Day 1) | 0.09x | 0.06x | - |
Infinium Pharmachem FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from Operations (Rs in millions) | Cash Flow from Operations (Rs in millions) | Free Cash Flow (Rs in millions) |
| H1FY23 | 60.0 | 792.8 | 19.5 | -13.4 |
| FY22 | 66.9 | 991.2 | 118.0 | 70.7 |
| FY21 | 27.3 | 705.3 | 72.9 | 22.1 |
| FY20 | 8.7 | 388.4 | 30.3 | 19.2 |
Infinium Pharmachem IPO SUBSCRIPTION STATUS DETAILS
Infinium Pharmachem had 1.9 M shares on offer
Infinium Pharmachem IPO offer price was ₹135
Infinium Pharmachem IPO minimum Investment was ₹135000
Infinium Pharmachem IPO issue size was ₹ 253.1 M
Infinium Pharmachem had a minimum lot size of 1000 Shares per application
Infinium Pharmachem NUMBER OF SHARES ON OFFER
Infinium Pharmachem IPO IMPORTANT DATES
| Issue Open Date | 31 Mar 2023 |
| Issue close Date | 05 Apr 2023 |
| Allotment Date | 11 Apr 2023 |
| Refund Date | 12 Apr 2023 |
| Demat Account Credit Date | 13 Apr 2023 |
| Listing Date | 17 Apr 2023 |
| Listing on Exchange(s) | NSE |
| Infinium Pharmachem Allotment Status | Exchange |
Infinium Pharmachem IPO subscription opened on 31 Mar 2023, and closed on 05 Apr 2023
IPO allotment for Infinium Pharmachem was finalized on Tuesday, 11 Apr 2023
IPO listing for Infinium Pharmachem was on NSE on Monday, 17 Apr 2023
Infinium Pharmachem IPO LISTING GAINS
| Issue Price (adjusted) | 67.5 |
| Listing Open Price | 141.5 |
| Listing Close Price | 147.8 |
| Listing Gain% | 4.8% |
| Current Gain% | 223.0% |
Infinium Pharmachem Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infinium Pharmachem Ltd. | 218 | 151.7 | 21.4 | -1.7 | 0.8 | 11.7 | 8.1 | 191.8 | 21.5 | 14.2 | 74.3 | 10.2 | -12.8 |
| Sun Pharmaceutical Industries Ltd. | 1944.4 | 466526.7 | 38.6 | 2.3 | 7.8 | 13.7 | 10.6 | 60433.8 | 10.8 | 11479.4 | 5 | 50.4 | 16.6 |
| Divi's Laboratories Ltd. | 8300 | 220338.9 | 75.3 | 2.8 | 19.6 | 15.3 | 12.8 | 11067 | 14 | 2568 | 17.2 | 110.2 | 26.8 |
| Torrent Pharmaceuticals Ltd. | 4924 | 187293.2 | 85.9 | 9.6 | 11.9 | 25.8 | 4.9 | 13886.2 | 20.3 | 2163.4 | 13.2 | 57.3 | 8.9 |
| Cipla Ltd. | 1467.7 | 118568.6 | 35.2 | -0.9 | 4.2 | 11.3 | 9.1 | 29044.6 | 2.2 | 3879.2 | -26.4 | 41.7 | -37.5 |
| Zydus Lifesciences Ltd. | 1119 | 112597.6 | 22.3 | 2.3 | 4.1 | 18.6 | 9.6 | 27657.9 | 17.6 | 5040 | 11.4 | 50.1 | 9.6 |
Infinium Pharmachem INFORMATION ON IPO ISSUE
About Infinium Pharmachem
Infinium Pharmachem was incorporated on November 2003. The company is in the business of manufacturing and supplying Iodine, iodine derivatives and active pharmaceutical ingredients.
Object of the Issue
- Marketing and branding expenses (including registration in REACH, a European commission, and other marketing expenses)
- Repayment of some of the existing loans and expansion of units
- To meet incremental working capital requirements
- To meet public issue expenses
Infinium Pharmachem - PROMOTERS
| Name |
|---|
| Sanjaykumar Viththalbhai Patel |
| Pravin Bhadabhai Madhani |
| Mitesh Lavjibhai Chikhaliya |
Infinium Pharmachem Book Running Lead Manager
Swastika Investmart Limited
merchantbanking@swastika.co.in
Infinium Pharmachem Registrar to the issue
Bigshare Services Private Limited
ipo@bigshareonline.com
Infinium Pharmachem Strengths
Expertise in research and development
The company has expertise in research and development. Over 250 iodine derivatives have been researched and developed
Expanding reach
The company has expanded its reach to over 15 countries across the globe, while significantly increasing its customer base in India too
Competitive marketing strategy
The company has a competitive marketing strategy garnering consistent growth in revenue
Infinium Pharmachem Risks
Use of hazardous chemicals
The manufacturing process involves the use of hazardous and flammable industrial chemicals which entails significant risks and could also result in enhanced compliance obligation
Competitive industry
The company operates in a highly competitive industry. Any inability to compete effectively may lead to a lower market share or reduced operating margins
IPO FAQs
Infinium Pharmachem Ltd. IPO listing opened at Rs 141.50 while the issue price was Rs 135.00 giving 4.81% returns. After adjusting for subsequent bonus and splits, the stock trades at Rs 67.50 giving 223.04% gains since its IPO listing.
The promoters of the company are Sanjaykumar Viththalbhai Patel, Pravin Bhadabhai Madhani and Mitesh Lavjibhai Chikhaliya.
The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.
The price band of the IPO is Rs 135.0 - 135.0.
The IPO application opens on Mar 31, 2023 and closes on Apr 05, 2023.
The minimum lot size for the IPO is 1000. The maximum lot size for the IPO is 1000.
For all category investors, the minimum application amount for this IPO is Rs. 135,000.0, the maximum value for this IPO is Rs 135,000.0.
This IPO will be allotted on Apr 11, 2023.
The refund will be credited to your account on Apr 12, 2023.
The allotted shares will be credited to your demat on Apr 13, 2023.
Infinium Pharmachem Ltd.’s shares listed on the stock exchanges on Apr 17, 2023.